Bio-Reference Laboratories, Inc. (BRLI)
| HelpRegister |
Bio-Reference Laboratories, Inc. (BRLI) It appears that BRLI has a extremely high short ratio of 38%. This means that a lot people are selling this stock short because they believe that the stock price will tank. I don't know if there is something going on with this company to have so many short sellers. Has anyone heard anything regarding the high short ratio? Thanks, Barbara Google BRLI + whistleblower and you'll find what is the most likely culprit. My club sold it due to this. Stu, Mad Loot Investment Club
Thanks Stu. From: Stuart Weissman <stuw6@yahoo.com> To: "club_cafe@bivio.com" <club_cafe@bivio.com> Sent: Tuesday, July 30, 2013 10:51 AM Subject: Re: [club_cafe] Bio-Reference Laboratories, Inc. (BRLI) Google BRLI + whistleblower and you'll find what is the most likely culprit. My club sold it due to this. Stu, Mad Loot Investment Club
I did the BRLI+whistleblower google and found this: http://www.wnd.com/markets/news/read?GUID=19914636 As always, vet your sources. Ed Berners, St Joe Valley Investors Club
Ed, I agree that we need to understand the motives of all involved, but let's think about how this works. The short seller, in this case the Streetsweeper, essentially operates by creating it's own view, just the same as any analyst. They provide as just enough credibility to convince a large number of people to sell the shares. This is the reverse of the "pump & dump" routines of the 1990's. Just my opinion, but when you consider the number of amendments BRLI has made to SEC filings, I have enough to say I don't understand this stock - from either the buy or sell perspective. It makes sense to avoid what I don't understand.
Mark Eckman On Tue, Jul 30, 2013 at 4:46 PM, Edgar Berners <eberners76@sbcglobal.net> wrote:
For another example of this and the unnecessary risk you take by investing in a stock with a negative story surrounding it (regardless of whether or not it is a legitimate claim), google EBIX. It makes little difference whether or not the pump and dump story is true. If you are on the wrong the side of the momentum, you will get crushed. Better off finding an equity without a story involved yet to be proven true or false. Personally, I've been burned once too many times trying to play superhero. Stu
Mark (or anyone),
Could you elaborate on the amendments to SEC Filings for BRLI (or any stock
for that matter)?
In BRLI's case it seems that the bulk of those have been to Form SC 13G -
Statement of Acquisition of Beneficial Ownership of Individuals. Would the
quantity of amendments be more serious if it were to 10-Q and 8-K reports as
opposed to the SC 13G or do you simply view the large number of amendments as
unacceptable sloppiness on the part of a company?
Thanks,
Nick
From: Stuart Weissman
Sent: Tuesday, July 30, 2013 9:10 PM
Subject: Re: [club_cafe] Fw: [club_cafe] Bio-Reference Laboratories,
Inc. (BRLI) For another example of this and the unnecessary risk you take by investing
in a stock with a negative story surrounding it (regardless of whether or not it
is a legitimate claim), google EBIX.
It
makes little difference whether or not the pump and dump story is true. If
you are on the wrong the side of the momentum, you will get crushed.
Better off finding an equity without a story involved yet to be proven true or
false. Personally, I've been burned once too many times trying to play
superhero.
Stu
Dear Nick, I don't think it is the quantity as much as the reasons for the amendments that is important. Back in 2011, there was correspondence between BRLI and the SEC questioning various items about their reporting. You can find those if you search for CORRESP when you go to the SEC link on this page: BRLI TIcker Research To me it is interesting to read things like this because they give you more of a sense of the management of the company. BRLI recently had to restate it's financial reports because of a change in method of revenue recognition. As an investor, it is important for you to understand that the change was made and the reasons for it especially if you are projecting future results based on historical data that does not have the adjustments applied to it. I think if you are an investor in BRLI and you do not understand these types of changes or the questions and responses during the SEC investigations a couple of years ago, then you are flying with blinders on. At a minimum, you might want to set up some downside protection if you hold the stock and it has risen quite a bit in a short time. This one seems pretty volatile: http://finance.yahoo.com/echarts?s=BRLI+Interactive#symbol=brli;range=2y;compare=;indicator=volume;charttype=area;crosshair=on;ohlcvalues=0;logscale=off;source=undefined; But, of course, it is up to you. That's what makes a market! Laurie Frederiksen
Invest with your friends! www.bivio.com Become our Facebook friend! www.facebook.com/bivio Follow us on twitter! www.twitter.com/bivio Follow Us on Google+ Click here to Subscribe to the Club Cafe email list. Click here to Unsubscribe On Wed, Jul 31, 2013 at 1:25 PM, Nick <telcontar11@verizon.net> wrote:
Nick, I think Laurie summed it up pretty well. The issues in 2011 are confusing and do relate to the 10-Q and 10-K filings. The SEC typically uses a comment letter to "jawbone" a company into an accounting procedure the SEC considers more appropriate. But when the SEC asks frequent questions and the answers are changes to details in footnotes or corrections, it becomes a sloppy pattern that is not understood by the readers of the financial statements.
I also have concerns with this much SEC activity regarding the audit firm. The original documents were approved by the auditor prior to filing, as were the corrections. If hundreds of other SEC registered firms can file 10-Qs and 10-Ks once and done, why can't BRLI? Why does this happen multiple times at BRLI? Constant changes to the how and why make analysis very difficult.
Changes to a SC 13G are not a concern. Those are filed by the investor, not the company. Mark Eckman On Wed, Jul 31, 2013 at 12:25 PM, Nick <telcontar11@verizon.net> wrote:
Mark and Laurie,
Thanks for your response and guidance.
From: Mark Eckman
Sent: Wednesday, July 31, 2013 3:16 PM
Subject: Re: [club_cafe] Fw: [club_cafe] Bio-Reference Laboratories,
Inc. (BRLI) Nick,
I think Laurie summed it up pretty well. The issues
in 2011 are confusing and do relate to the 10-Q and 10-K filings. The SEC
typically uses a comment letter to "jawbone" a company into an accounting
procedure the SEC considers more appropriate. But when the SEC asks
frequent questions and the answers are changes to details in footnotes or
corrections, it becomes a sloppy pattern that is not understood by the readers
of the financial statements.
I also have concerns with this much SEC activity
regarding the audit firm. The original documents were approved by the
auditor prior to filing, as were the corrections. If hundreds of other SEC
registered firms can file 10-Qs and 10-Ks once and done, why can't
BRLI? Why does this happen multiple times at BRLI? Constant
changes to the how and why make analysis very difficult.
Changes to a SC 13G are not a concern. Those are
filed by the investor, not the company.
Mark Eckman
On Wed, Jul 31, 2013 at 12:25 PM, Nick <telcontar11@verizon.net> wrote:
|
|
||||||